SEB Asset Management AB »

Zenas Biopharma shares owned by SEB Asset Management AB

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by SEB Asset Management AB from 13F filings

Historical chart of SEB Asset Management AB investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by SEB Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by SEB Asset Management AB

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.2M 164k 19.55

More positions owned by SEB Asset Management AB

NVIDIA Corporation (NVDA)
Apple (AAPL)
Astrazeneca Ord (AZN)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Tesla Motors (TSLA)

View all positions for SEB Asset Management AB

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
Capital Research and Management Company - Division 3
Fairmount Funds Management
BlackRock
NVP Associates
Vanguard Group
Vanguard Capital Management
Polar Capital Holdings
Alliancebernstein
Wellington Management Company
EcoR1 Capital

View all funds holding Zenas Biopharma